annual CFI:
-$8.57M-$3.59M(-72.15%)Summary
- As of today (June 22, 2025), ADMA annual cash flow from investing activities is -$8.57 million, with the most recent change of -$3.59 million (-72.15%) on December 31, 2024.
- During the last 3 years, ADMA annual CFI has risen by +$4.94 million (+36.53%).
- ADMA annual CFI is now -156.36% below its all-time high of $15.21 million, reached on December 31, 2017.
Performance
ADMA Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
-$4.72M-$1.97M(-71.64%)Summary
- As of today (June 22, 2025), ADMA quarterly cash flow from investing activities is -$4.72 million, with the most recent change of -$1.97 million (-71.64%) on March 31, 2025.
- Over the past year, ADMA quarterly CFI has dropped by -$2.36 million (-99.83%).
- ADMA quarterly CFI is now -137.31% below its all-time high of $12.65 million, reached on June 30, 2017.
Performance
ADMA quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
-$10.93M-$2.36M(-27.50%)Summary
- As of today (June 22, 2025), ADMA TTM cash flow from investing activities is -$10.93 million, with the most recent change of -$2.36 million (-27.50%) on March 31, 2025.
- Over the past year, ADMA TTM CFI has dropped by -$5.54 million (-102.54%).
- ADMA TTM CFI is now -146.21% below its all-time high of $23.66 million, reached on June 30, 2017.
Performance
ADMA TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
ADMA Cash from investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -72.2% | -99.8% | -102.5% |
| 3 y3 years | +36.5% | -66.1% | +20.7% |
| 5 y5 years | -125.0% | -127.7% | -89.3% |
ADMA Cash from investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -72.2% | +38.4% | -523.5% | at low | -119.5% | +21.4% |
| 5 y | 5-year | -125.0% | +38.4% | -523.5% | at low | -119.5% | +21.4% |
| alltime | all time | -156.4% | +38.4% | -137.3% | +45.2% | -146.2% | +21.4% |
ADMA Cash from investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$4.72M(+71.6%) | -$10.93M(+27.5%) |
| Dec 2024 | -$8.57M(+72.2%) | -$2.75M(+150.5%) | -$8.57M(+18.6%) |
| Sep 2024 | - | -$1.10M(-53.6%) | -$7.23M(+4.9%) |
| Jun 2024 | - | -$2.37M(+0.1%) | -$6.89M(+27.7%) |
| Mar 2024 | - | -$2.36M(+67.9%) | -$5.40M(+8.4%) |
| Dec 2023 | -$4.98M(-64.2%) | -$1.41M(+85.9%) | -$4.98M(-32.0%) |
| Sep 2023 | - | -$757.00K(-13.2%) | -$7.32M(-26.4%) |
| Jun 2023 | - | -$872.00K(-55.2%) | -$9.95M(-23.6%) |
| Mar 2023 | - | -$1.95M(-48.1%) | -$13.01M(-6.4%) |
| Dec 2022 | -$13.91M(+3.0%) | -$3.75M(+10.9%) | -$13.91M(+0.5%) |
| Sep 2022 | - | -$3.38M(-14.2%) | -$13.84M(+4.5%) |
| Jun 2022 | - | -$3.94M(+38.6%) | -$13.25M(-3.9%) |
| Mar 2022 | - | -$2.84M(-22.7%) | -$13.78M(+2.0%) |
| Dec 2021 | -$13.51M(+6.2%) | -$3.68M(+31.8%) | -$13.51M(+0.6%) |
| Sep 2021 | - | -$2.79M(-37.7%) | -$13.43M(-0.7%) |
| Jun 2021 | - | -$4.48M(+74.1%) | -$13.53M(+2.3%) |
| Mar 2021 | - | -$2.57M(-28.5%) | -$13.22M(+3.9%) |
| Dec 2020 | -$12.72M(+233.8%) | -$3.60M(+24.7%) | -$12.72M(+18.7%) |
| Sep 2020 | - | -$2.89M(-30.8%) | -$10.72M(+9.3%) |
| Jun 2020 | - | -$4.17M(+101.1%) | -$9.81M(+69.8%) |
| Mar 2020 | - | -$2.07M(+30.0%) | -$5.77M(+51.5%) |
| Dec 2019 | -$3.81M(+81.9%) | -$1.59M(-19.1%) | -$3.81M(+25.5%) |
| Sep 2019 | - | -$1.97M(+1358.5%) | -$3.04M(+134.5%) |
| Jun 2019 | - | -$135.20K(+22.4%) | -$1.29M(-21.8%) |
| Mar 2019 | - | -$110.50K(-86.5%) | -$1.66M(-20.9%) |
| Dec 2018 | -$2.10M(-113.8%) | -$819.00K(+255.8%) | -$2.10M(-36.2%) |
| Sep 2018 | - | -$230.20K(-53.7%) | -$3.29M(-9.4%) |
| Jun 2018 | - | -$497.10K(-9.5%) | -$3.63M(-138.1%) |
| Mar 2018 | - | -$549.20K(-72.7%) | $9.52M(-37.4%) |
| Dec 2017 | $15.21M | -$2.01M(+252.7%) | $15.21M(-33.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2017 | - | -$569.90K(-104.5%) | $22.85M(-3.4%) |
| Jun 2017 | - | $12.65M(+146.1%) | $23.66M(+889.8%) |
| Mar 2017 | - | $5.14M(-8.6%) | $2.39M(+164.2%) |
| Dec 2016 | $904.60K(-151.9%) | $5.63M(+2255.2%) | $904.60K(+33.3%) |
| Sep 2016 | - | $238.90K(-102.8%) | $678.80K(-85.2%) |
| Jun 2016 | - | -$8.62M(-335.7%) | $4.60M(-47.7%) |
| Mar 2016 | - | $3.66M(-32.3%) | $8.79M(-604.6%) |
| Dec 2015 | -$1.74M(-56.9%) | $5.40M(+29.9%) | -$1.74M(-71.1%) |
| Sep 2015 | - | $4.16M(-193.9%) | -$6.03M(-48.0%) |
| Jun 2015 | - | -$4.43M(-35.6%) | -$11.59M(+0.5%) |
| Mar 2015 | - | -$6.87M(-718.9%) | -$11.53M(+185.5%) |
| Dec 2014 | -$4.04M(+29.0%) | $1.11M(-179.2%) | -$4.04M(-50.1%) |
| Sep 2014 | - | -$1.40M(-67.9%) | -$8.09M(+20.7%) |
| Jun 2014 | - | -$4.37M(-804.5%) | -$6.71M(+174.2%) |
| Mar 2014 | - | $620.20K(-121.1%) | -$2.45M(-21.9%) |
| Dec 2013 | -$3.13M(+2534.0%) | -$2.94M(>+9900.0%) | -$3.13M(+1282.7%) |
| Sep 2013 | - | -$16.40K(-84.9%) | -$226.50K(-4.6%) |
| Jun 2013 | - | -$108.70K(+64.4%) | -$237.50K(+28.4%) |
| Mar 2013 | - | -$66.10K(+87.3%) | -$185.00K(+55.6%) |
| Dec 2012 | -$118.90K(<-9900.0%) | -$35.30K(+28.8%) | -$118.90K(+42.2%) |
| Sep 2012 | - | -$27.40K(-51.2%) | -$83.60K(+48.8%) |
| Jun 2012 | - | -$56.20K(<-9900.0%) | -$56.20K(<-9900.0%) |
| Mar 2012 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2011 | - | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2011 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2011 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2011 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2010 | - | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2010 | - | $0.00 | $0.00 |
| Jun 2010 | $0.00 | - | - |
FAQ
- What is ADMA Biologics annual cash flow from investing activities?
- What is the all time high annual CFI for ADMA Biologics?
- What is ADMA Biologics annual CFI year-on-year change?
- What is ADMA Biologics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for ADMA Biologics?
- What is ADMA Biologics quarterly CFI year-on-year change?
- What is ADMA Biologics TTM cash flow from investing activities?
- What is the all time high TTM CFI for ADMA Biologics?
- What is ADMA Biologics TTM CFI year-on-year change?
What is ADMA Biologics annual cash flow from investing activities?
The current annual CFI of ADMA is -$8.57M
What is the all time high annual CFI for ADMA Biologics?
ADMA Biologics all-time high annual cash flow from investing activities is $15.21M
What is ADMA Biologics annual CFI year-on-year change?
Over the past year, ADMA annual cash flow from investing activities has changed by -$3.59M (-72.15%)
What is ADMA Biologics quarterly cash flow from investing activities?
The current quarterly CFI of ADMA is -$4.72M
What is the all time high quarterly CFI for ADMA Biologics?
ADMA Biologics all-time high quarterly cash flow from investing activities is $12.65M
What is ADMA Biologics quarterly CFI year-on-year change?
Over the past year, ADMA quarterly cash flow from investing activities has changed by -$2.36M (-99.83%)
What is ADMA Biologics TTM cash flow from investing activities?
The current TTM CFI of ADMA is -$10.93M
What is the all time high TTM CFI for ADMA Biologics?
ADMA Biologics all-time high TTM cash flow from investing activities is $23.66M
What is ADMA Biologics TTM CFI year-on-year change?
Over the past year, ADMA TTM cash flow from investing activities has changed by -$5.54M (-102.54%)